OS by PD-L1 Expression
1.
1. Paz-Ares L et al.; J Clin Oncol 33, 2015 (suppl; abstr LBA109
)
Checkmate 057 – Biomarker-Analysis: OS benefit in the ITT population
in PD-L1 expressing tumors